AMGN and ZLAB Related Headlines

Go Back

Apr 1, 2026 07:30AM Zai Lab partners with Amgen for combination cancer therapy trial

Apr 1, 2026 07:30AM Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

Sep 3, 2025 10:48AM Zai Lab pauses regulatory filing for bemarituzumab after trial results

AMGN and ZLAB Related Press Releases

Go Back

Apr 1, 2026 07:30AM Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

AMGN and ZLAB Related SEC Filings

Go Back